Low dose intravenous bevacizumab for the treatment of anaemia in hereditary haemorrhagic telangiectasia

British Journal of Haematology

Volumn 152, Issue 4, 2011, Pages 365-365

  Patrizia, Suppressa ^a   Arcangelo, Liso ^b   Carlo, Sabbà ^a  

^a POLICLINICO   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; HEMOGLOBIN;

ADULT; ANEMIA; CASE REPORT; DISEASE SEVERITY; EPISTAXIS; ERYTHROCYTE TRANSFUSION; FACE PROFILE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LOW DRUG DOSE; MALE; MELENA; MULTIPLE CYCLE TREATMENT; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE; RENDU OSLER WEBER DISEASE; SKIN DISEASE; SKIN TELANGIECTASIA; THROMBOCYTE COUNT;

ANEMIA; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DRUG ADMINISTRATION SCHEDULE; FACIAL DERMATOSES; HUMANS; MALE; MIDDLE AGED; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 78851472558     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08481.x     Document Type: Note

References (0)